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Abstract
A published review of the literature by Dutch investigators in 2004 suggested significant outcome differences between
spontaneously - and in vitro fertilization (IVF) - conceived singleton and twin pregnancies. Here we review whether later
studies between 2004–2015 confirmed these findings. Though methodologies of here reviewed studies varied, and all
were retrospective, they overall confirmed results of the 2004 review, and supported significant outcome variances
between spontaneously- and IVF-conceived pregnancies: IVF singletons demonstrate significantly poorer and IVF twins
significantly better perinatal outcomes than spontaneously conceived singletons and twins, with differences stable over
time, and with overall obstetrical outcomes significantly improved. Exaggerations of severe IVF twin risks are likely in the
50 % range, while exaggerations of milder perinatal risks are approximately in 25 % range. Though elective single
embryo transfers (eSET) have been confirmed to reduce pregnancy chances, they are, nevertheless, increasingly
utilized. eSET, equally unquestionably, however, reduces twin pregnancies. Because twin pregnancies have been
alleged to increase outcome risks in comparison to singleton pregnancies, here reported findings should affect the
ongoing discussion whether increased twin risks are factual. With no risk excess, eSET significantly reduces IVF pregnancy
chances without compensatory benefits and, therefore, is not advisable in IVF, unless patients do not wish to conceive
twins or have medical contraindications to conceiving twins.
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Background
A groundbreaking study by Templeton and Morris in 1998
[1] ended with remarkable speed the worldwide glut of
high order multiple births with in vitro fertilization (IVF).
Improvements in implantation rates without concomitant
changes in the clinical practice of transferring multiple em-
bryos had been the cause of this glut. Templeton and
Morris accomplished this remarkable feat by demonstrat-
ing that in younger, good-prognosis patients transfer of
two embryos (2ET) sufficed to achieve excellent pregnancy
rates, while avoiding high-order multiples from triplets
onwards. Not less important was their concomitant ob-
servation that following 2ET, pregnancy success was in
good-prognosis patients not diminished in comparison
to transfers with more embryos.
The transition from multiple embryo transfer to 2ET,
therefore, went smoothly and quickly because Temple-
ton and Morris demonstrated that this practice change
improved outcomes (i.e., significantly lowered the poten-
tially risky high-order multiples) without incurring any
detrimental outcome effects (pregnancy rates remained
the same).
This at the time quite revolutionary step in the develop-
ment of IVF, however, has to be differentiated from argu-
ments in favor of elective single embryo transfer (eST),
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first proposed by Vilska et al. in 1999 [2]. Still dissatisfied
by the high twin pregnancy rates with 2ET, these authors
proposed that 2ET be replaced by eSET since only births
of singleton offspring should be considered desirable IVF
outcomes. Singleton pregnancies, of course, could only be
“guaranteed” by broad utilization eSET.
Since eSET unquestionably, reduces pregnancy and de-
livery chances [3], in contrast to Templeton and Morris’
switch from multiple embryo transfer to 2ET, switching
from 2ET to eSET even in good-prognosis patients came
at considerable cost. For proponents of eSET such a price
tag was warranted because twin births were supposedly
associated with significantly higher complication rates
than singletons, and, therefore, also increased costs to so-
ciety [4].
The assumption that IVF-associated twin pregnan-
cies are riskier and costlier for mothers and offspring
(and society) than singleton deliveries, thus, represents
the core of all advocacy in favor of eSET. Should this
basic assumption be proven false, then there no longer
exist medical indications for eSET since it clearly re-
duces pregnancy and live birth chances [3]. The only
remaining indications for eSET then would be patients
who wish to avoid twins or exhibit medical contraindi-
cations to conceiving twins.
Since our analyses of the literature suggested that in a
prospective infertility treatment paradigm claims of sig-
nificantly increased maternal and neonatal twin risks
were statistically flawed, we have previously disagreed
with the concept of eSET [5, 6].
Our reasoning is based on: (i) Correct statistical ana-
lyses require risk outcome comparisons for similar out-
comes. As twin pregnancies produce two, and singleton
pregnancies only one offspring, this most basic statistical
rule is not met by comparing outcomes between one
twin and one singleton pregnancy. While such a com-
parison is appropriate in a retrospective obstetrical para-
digm, it is flawed in a prospective infertility paradigm,
where patients and treating physicians are seeking best
treatment for patients who are desirous of at least two
more children. In such a paradigm, the correct statistical
comparison is a comparison of one twin pregnancy to
two consecutive singleton pregnancies, with both ultim-
ately resulting in birth of two children.
We are aware of only three studies that investigated risk
comparisons correctly. All other studies in the literature,
therefore the vast majority on which eSET is based, uti-
lized statistically inappropriate retrospective comparisons
of one twin to one singleton pregnancy. Data of all three
properly conducted studies were very similar, and no lon-
ger demonstrated significantly increased risk profiles for
IVF twin pregnancies.
Of those three studies, however, only one recent Swedish
study had been published by time of submission of this
manuscript [7]. We had the opportunity to see the other
two studies during the peer review process, and one of
them has since also appeared electronically [8]. Both pub-
lished studies demonstrated very similar results in still
reporting mildly higher perinatal risks for twins than two
consecutive singletons; but the recorded increased risks
were clinically really irrelevant and compensated by some
decreased risks in consecutive singleton pregnancies, es-
pecially in the Swedish study.
As previously noted, the authors of the Swedish study,
unfortunately, misinterpreted their own results [7]. Cor-
rectly interpreted, the Swedish study also demonstrates no
longer clinically significant increased risks for mothers
and offspring in twin pregnancies. The only significant
findings were higher cesarean section rates and a minimal
increase in mild prematurity, with no reflection whatso-
ever in neonatal morbidity and mortality or even NCIU
admissions. Remarkably, the study by La Sala et al. also
demonstrated no increase in NCIU admissions but dem-
onstrated significantly increased miscarriage rates with
two consecutive singleton pregnancies [8].
Both of these studies, therefore, confirm what we con-
cluded from reanalyzes of published data of other study
formats [5, 6, 9] that, if outcome comparisons are cor-
rectly made in a prospective fertility paradigm, twin preg-
nancies in comparison to two singleton pregnancies, no
longer appear to demonstrate clinically significant in-
creased perinatal risks.
(ii) But in addressing this issue, a second statistical error
in the medical literature also requires correction, and is
the primary subject of here presented review: Studies
claiming increased twin risks also assumed that maternal
and neonatal outcomes of spontaneously conceived preg-
nancies and those conceived via IVF are the same. How-
ever, already in 2004, Helmerhorst et al. concluded after
reviewing the literature that IVF-conceived twins experi-
enced approximately 40 % lower perinatal outcome risks
than spontaneously conceived twins, while IVF-conceived
singletons actually demonstrated significantly increased
perinatal risks in comparison to spontaneously conceived
singletons [10]. These two opposing observations for
singleton and twin pregnancies, therefore, suggested
that, independently from above under (i) described stat-
istical considerations, IVF twin risks in comparison to
IVF singleton pregnancies are, likely, significantly over-
estimated for yet another reason [5, 6, 9].
We here, therefore, present a reviews of published data
on this subject since Helmerhorst’s publication over a
decade ago in order to determine whether those findings
have been holding up under more current practice.
Sources
We systematically reviewed the English literature be-
tween 2004 and 2015 for articles that addressed outcome
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comparisons between spontaneously conceived and IVF-
conceived singleton pregnancies and/or twin pregnan-
cies. Searches were conducted under appropriate key
words via PubMed, Medline and the Cochran Library.
We also checked Clinical.Trials.gov for ongoing studies
on the subject. Based on suggestions during the review
process, we also searched Popline, EMBASE and Web
Science but were unable to discover additional relevant
publications in English.
To preclude outcome biases from single center prac-
tices, we concentrated the search on systemic reviews and
on publications using multicenter and/or national data
sets, and excluded publications that reported only single
center experiences involving only small patient samples.
The principal reason for this decision was that we did not
want outcome comparisons to be potentially biased by ob-
stetrical/neonatal practice patterns, which do not repre-
sent widely practiced standard of care. Considering widely
differing study designs in all published studies, which did
not allow for a meta-analysis of published data, our statis-
ticians advised us to avoid small, single center studies that
could introduce single center practice biases.
Since keywords could not reflect the here reviewed
subject in isolation, we conducted our data base search
with the following phrases: <outcome comparisons/cost
comparisons/maternal outcome comparisons/perinatal
outcome comparisons/neonatal outcome comparisons
between spontaneous and IVF/ART pregnancies > .
Figure 1 summarizes the flow of information.
Study selection
We identified 23 records through database searches,
added an additional 4 via reference list searches and an
additional during the review process for a total of 28 re-
cords, which were screened by one of the authors (N.G.)
Sixteen were identified as irrelevant to here discussed
subject. The remaining 12 articles were assessed for eli-
gibility by all three authors, among those a relatively re-
cent publication from Sweden [7], which we recently
reviewed elsewhere in detail [9].
Three studies were disqualified from further evaluation
because they reported small data sets from single centers,
where center-specific clinical practice patterns could have
influenced outcomes. This study, therefore presents data
from 8 publications, all either large multicenter, national
or multinational data sets. Table 1 summarizes them in
order of historical appearance in the literature.
Because methodologies and study end points greatly
varied, a metaanalysis of reported data was not possible.
The table, however, attempts to summarize individual
study outcomes in their relevance.
Results
The first study addressing the issue after Helmerhorst’s
review of the literature [10] was by the Swedish group of
Källén et al. [11]. Using national health registries in Sweden
for the period of 1982–2007, they compared 1545 pairs of
different-sex (dizygotic) twins born after IVF with 8675
non-IVF dizygotic twin pairs. Main outcomes were length
of gestation, birth weight, respiratory complications and
jaundice. As the only statistically significant finding, they
reported in IVF-twins increased risk for preterm delivery
before 32 weeks gestational age.
These results not only contradict the data accumulated
by Helmerhorst et al. [10], but also data of all other later
studies published on this subject, listed in Table 1. They
Fig. 1 Flow of information according to PRISMA guidelines
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are also contradicted by this study’s own finding of no
difference in low birth weights. It is difficult to under-
stand how prematurity under 32 weeks can be more
prevalent; yet, birth weights are not.
The authors, themselves, indeed, raised doubts about
the reliability of their data sets, and the length of time
(25 years) in which these outcomes accumulated. Such a
time span, of course, involves significant practice changes.
Among subsequently performed studies, only the
study by Anbazhagan et al. demonstrated no differ-
ences between IVF-conceived and spontaneously con-
ceived pregnancies [12]. All other studies, indeed, did
demonstrate statistically highly significant differences
between IVF-associated and spontaneously conceived
gestations; with IVF-singletons uniformly doing much
poorer than spontaneously conceived singletons, and
IVF-conceived twins doing much better than spontan-
eously conceived twins (Table 1).
The Table also demonstrates, based on the studies by
Dar et al. [13] and Henningsen et al., [14] that, as one
would expect, perinatal/neonatal outcomes have not
remained static over time but have been improving for
singletons as well as twin deliveries. This observation,
alone, reemphasizes the need for utilization of contem-
porary risk outcome data when comparing outcome
risks between singleton and twin pregnancies.
As the table also demonstrates, adjusted odds ratios
(AORs) vary, depending on which outcomes are assessed;
but studies by Pinborg et al. [15], Hennigsen et al. [14, 16]
and Declercq et al. [17] do suggest that obstetrical out-
come studies in spontaneously conceived pregnancies vary
from IVF-conceived pregnancies approximately by a com-
bined AOR of 0.25–0.50, with IVF twins doing much bet-
ter and IVF singletons much poorer. These results also
suggest that overestimations of twin risks increase with
severity of risk. In other words, risk exaggeration for
Table 1 Comparisons of obstetrical outcomes between spontaneously conceived and IVF pregnancies
Authors Year Study format Singletons Twins Comments
Källén et al [11] 2010 National X Significant increase in IVF of PTB (<32 weeks); No difference
in LBW
Pinborg et al [15] 2013 Review AOR 1.27, (95 % CI
1.08, 1,49)
Even in same mother an IVF offspring has more PTB
than non-IVF
Offspring
Sazonova et al [7] 2013 This study is only indirectly relevant to here reviewed subject but is listed because it is the only study, which correctly
compared in a large national population outcomes of twin pregnancies in comparison to two consecutive singleton
pregnancies. Unfortunately, as previously in detail reviewed by us, the authors misrepresented their data in discussing
their conclusions [9]. A correct analysis of their data demonstrated no clinically significant outcome differences in either
maternal or neonatal outcomes, with AORs listed in the reference. The study, however, did not comment on
differences between spontaneously- and IVF-conceived pregnancies.
Anbazahagan et al [12] 2014 MCPT no significant
difference
X No difference between IVF and spont. twins but small
size and prospective study
Henningsen et al [16] 2014 Scandinavian
population study
AOR 1.54 (95 % CI
1.28, 1.85)
X IVF singletons had increased neonatal death risk. IVF
twins had lower risk, which was lost when restricted to
opposite-sex twins
Dar et al [13] 2014 Review and meta-analysis; Study does not comment on differences In outcomes between spontaneously and IVF-conceived
singletons and twins but demonstrates significantly increased PTB risk for blastocyststage embryo transfer in comparison to
cleavage-stage embryo transfer, a finding with relevance to here discussed topic since blastocyst-stage embryo transfer is a
prerequisite for eSET.
Declercq et al [17] 2015 Cohort AOR for PTB 1.23
AOR for LBW 1.26
Both AORs are in comparison to a subfertile patient
group: Risks of singletons among IVF patients and in a
sub-fertile patient group were, both, higher than in
normally fertile population.
AOR for PD 0.55 in
comparison to fertile
controls
AOR for PF 0.15
in comparison to
subfertile controls
Henningsen et al [14] 2015 Cross-border Scandinavian cohort study demonstrating significant declines over last 20 years in stillbirth and infant
deaths for IVF singletons and twin deliveries, with “fewer” IVF twins being stiiborn or died during year 1 of life
compared to spontaneously conceived twins (presumably due to fewer monozygotic twins among IVF twins).
In addition IVF singletons demonstrated a significant decline in being born preterm and very preterm.
AOR adjusted odds ratio; PTB preterm birth; X – in comparison to; MCPT multicenter prospective trial, LBW low birth weight; PD, perinatal death
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perinatal/neonatal death carries an AOR of approximately
0.50 (i.e., appears overestimated by ca. 50 % for IVF twins),
while milder risks, such as preterm birth or low birth
weight carry overestimates of AOR of only approximately
0.25 (i.e., 25 %). These results, thus, fully confirm the earl-
ier analysis of the literature by Helmerhorst et al. in 2004
[10] and, in addition, add significant further detail.
The study by Declercq et al. adds further subtlety be-
cause it for the first time also presents data on a sub-fertile
(i.e., infertile patient population receiving treatments other
than IVF) non-IVF control group. It demonstrates that this
additional patient group falls in respective risk in-between
spontaneously conceived and IVF-conceived pregnancies
(Table 1) [17]. This observation, therefore, further validates
prior and more recent observations of divergent risk pro-
files for singleton and twin pregnancies, depending on
mode of conception.
Discussion
Here presented review confirms the significant divergence
of risks for IVF- and spontaneously conceived single-
ton and twin pregnancies, already in 2004 reported by
Helmerhorst et al. [10]. Moreover, this review suggests
that the risk divergence, reported by Helmerhorst et al.,
despite generally improving perinatal and neonatal out-
comes for singleton as well as twin pregnancies has been
approximately maintained.
As this study also revealed, recently published pa-
pers on this subject suffer from the same shortcomings
Helmerhorst et al. decried when, first time, investigating
this subject over 10 years ago [10]. Studying this subject
by metaanalysis was, therefore, then and now impossible,
though the consistency of findings between both studies is
quite remarkable.
Since published perinatal/neonatal risk assessments of
singletons and twins almost uniformly have been ob-
tained from spontaneously conceiving obstetrical popu-
lations, they, therefore, indisputably exaggerate IVF-twin
risks and underestimate IVF-singleton risks. At least for
the most severe risks, like perinatal/neonatal deaths, risk
exaggerations may be as high as 50 %, while milder risks
may carry only biases of ca. 25 %.
None of the reviewed studies offer robust evidence for
the reasons of observed discrepancies between spontan-
eous – and IVF-conceived pregnancies, and one is, there-
fore, left with only hypotheses: IVF twin pregnancies may
demonstrate better outcomes since these pregnancies are
recognized earlier than spontaneously conceived twins
and, therefore, very likely receive more “tender loving care”
at early stages of pregnancy. Early diagnosis of twin preg-
nancy may offer disproportionally more benefits than early
diagnosis of singletons, since twin pregnancy, of course,
carry significantly higher early pregnancy risks.
Here reaffirmed evidence of significant outcome differ-
ences between spontaneously – and IVF – conceived preg-
nancies raises additional doubts that IVF-associated twin
pregnancies, indeed, increase perinatal risks in comparison
to IVF-associated singleton births. If one then adds that his-
torical comparisons of twin to single birth also overestimate
twin risks by almost) 50 % (one study paradoxically claimed
that second consecutive singleton deliveries demonstrate
lower outcome risks than first singleton deliveries [7]),
one is at best left with significant doubts and, likely, with a
degree of conviction that alleged higher IVF-twin risks
really may not exist.
Increased IVF-twin risks, however, represent the pri-
mary rational for the concept of eSET. In absence of an
alleged increased risk associated with IVF twins, there
is absolutely no reason for eSET because the literature
undisputedly demonstrates that eSET reduces preg-
nancy chances in comparison to the transfer of two em-
bryos [18]. The study of La Sala et al. again confirmed
this fact in a single twin to two consecutive singleton
pregnancy comparison [8].
Our review revealed yet another paradox in the current
clinical utilization of eSET: The concept of embryo selec-
tion, as currently practiced, is, of course, closely related to
the concept of eSET via attempts of selecting best em-
bryos by blastocyst-stage culture and subsequent eSET at
blastocyst stage (days 5/6 after fertilization). Dar et al.,
following a systematic review of the literature, recently,
however, reported that blastocyst stage embryo transfer
significantly increases the risk of preterm births for single-
ton IVF pregnancies in comparison to earlier (day 3)
cleavage stage embryo transfers (AOR 1.32) [13]. In other
words, embryo selection by blastocyst stage culture, pri-
marily performed to select “best” embryos for eSET, actu-
ally significantly increases perinatal risks for singleton IVF
pregnancies, thus providing further support for the argu-
ment that twin IVF pregnancy risks are significantly over-
estimated in comparison to IVF singleton risks.
The principal limitation of this study is absence of
prospective studies, and of studies that correctly com-
pare outcomes in IVF patients leading to births of two
children between one twin and two consecutive single-
ton pregnancies. Since such studies are not available
(and, likely, will not become available in the foreseeable
future), clinical conclusions have to rely on individual
study analyses, as here presented.
A better understanding of advantages and disadvantages
of eSET, in our opinion, is of essence, as national IVF out-
comes all over the world are affected by increasing
utilization of eSET. While these trends, unquestionably,
reduce twin pregnancies, they also to significant degrees
appear to reduce regional IVF pregnancy rates in many
parts of the world [19]. If reduction in twin pregnancies is
a worthwhile compensatory expense for decreasing
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pregnancy and live birth rates, then further promotion of
eSET policies would appear warranted. If, however, as by
this study suggested, twin pregnancies do not produce
added perinatal risk, then the significant decline in clinical
pregnancy rates and an almost 40 % decline in live births
in the Canadian province of Québec following introduc-
tion of a provincial eSET mandate [20], would have to
considered poor public health policy, and propagation of
eSET policies by professional societies, insurance compan-
ies and government agencies should be abandoned.
Conclusions
Here presented data raise serious questions about the rap-
idly expanding IVF practice of prolonged embryo culture
to blastocyst stage, followed by eSET. Since it is undis-
puted that eSET reduces clinical pregnancy chances in IVF
when compared to two-embryo transfers [8, 18], propo-
nents of eSET consider such reductions in pregnancy po-
tential appropriately compensated by decreased maternal
and especially neonatal risks from avoided twin pregnan-
cies. In absence of increased risks from twin pregnancies,
patient would, however, be only left with a deficit in preg-
nancy chances, and without compensatory benefits of any
kind. Here presented review, therefore, adds significant
doubts about the medical and economic validity of eSET.
The concept of eSET, therefore, requires serious re-
consideration, unless patients want only one child to
complete their family or have medical contraindications
to twin pregnancies. In all other cases, eSET, as currently
increasingly considered standard of care, actually, likely,
harms pregnancy chances of infertile patients undergo-
ing IVF cycles, therefore unnecessarily prolonging their
time to pregnancy and increasing their medical costs.
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